new listings
PBS listing for first pan-genotypic antiviral hep C treatment
Hepatitis Australia has welcomed today’s announcement that a new hepatitis C drug will be listed on the PBS Epclusa, the first pan-genotypic antiviral, will be PBS listed from 1 August, …
New PBS listings
Health Minister Greg Hunt has highlighted a number of new drugs to gain PBS listing The new listings are worth $142 million, Mr Hunt says. Vorinostat (Zolinza) will be available …
Hunt highlights new PBS listings
New medicines worth $310 million have been added to the PBS this week, the Health Minister has announced The drugs were added to the PBS on Monday this week, with …
Patients need fast access to new medicines: McBride
Labor MP and pharmacist Emma McBride has spoken in support of the Therapeutic Goods Amendment Bill… with some caveats In speaking on the Therapeutic Goods Amendment (2016 Measures No.1) Bill …
New ovarian cancer drug listed
A new drug therapy for women with advanced ovarian cancer has been listed on the PBS as of today – which is also the first day of Ovarian Cancer Awareness …
New once-daily Hep C treatment recommended for PBS
The first and only one-tablet, once-a-day treatment for all genotypes of chronic hepatitis C infection has been recommended for PBS listing Gilead Sciences Australia has announced that the TGA has …
Another $70 million in new medicines listed
The Government has subsidised another $70 million round of new revolutionary medicines that will make treatments for Type 2 diabetes cheaper and more accessible and also help save the lives …
SHPA supports improved access, new listings
The Society of Hospital Pharmacists of Australia has declared its support for faster and improved access to vital medicines and medical devices as announced in the 2016 Federal Budget. “The …
New therapies for hep C listed
New therapies have been PBS listed for the treatment of genotype 1 chronic hepatitis C virus. AbbVie Australia today announced that Viekira Pak (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) and …
New chemo listing in indolent Non-Hodgkin’s Lymphoma
A cancer medicine that doubles progression free survival in people with indolent Non-Hodgkin’s Lymphoma and is less toxic than previous chemotherapy regimens will be added to the Pharmaceutical Benefits Scheme …
Fast facts on the new Hep C drugs
Professor Lisa Nissen, Debbie Rigby and Chris Campbell’s fast facts on the new Hepatitis C drugs… In Australia it is estimated that more than 230,000 patients were living with chronic …
Hep C drugs: cash flow, interactions and raising awareness
New pharmacy training to understand and dispense the new direct acting antiviral oral regimens for Hepatitis C will be available in May, but pharmacists need to learn as much as …